ResearcherUniversity of IsfahanActive in the last 2 years

Fariba Dehghanian

ORCID-verified (high confidence)As of 11 November 2026

Matched on ORCID iD 0000-0003-3357-5903; OpenAlex author ID A5081190676.

Their work

Papers: 3 (first author 2, last author 0)
Trials: 0
Grants: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

Deciphering the molecular crosstalk between type 2 diabetes and pancreatic cancer through cross-disease co-expression network analysis. First author DOI 10.1016/j.bbrep.2026.102562 ↗
Dissecting lncRNA-mRNA regulatory network in type 2 diabetes as the risk factor of pancreatic cancer. Co-author DOI 10.1038/s41598-025-21200-5 ↗
Non-coding RNAs underlying the pathophysiological links between type 2 diabetes and pancreatic cancer: A systematic review. First author DOI 10.1111/jdi.13727 ↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Amin Bahreini · 2 shared papers, 2025–2026
- Paper Deciphering the molecular crosstalk between type 2 diabetes and pancreatic cancer through cross-disease co-expression n… DOI 10.1016/j.bbrep.2026.102562 ↗
- Paper Dissecting lncRNA-mRNA regulatory network in type 2 diabetes as the risk factor of pancreatic cancer. DOI 10.1038/s41598-025-21200-5 ↗
Amirhossein Naghsh Nilchi · 1 shared paper, 2025
- Paper Dissecting lncRNA-mRNA regulatory network in type 2 diabetes as the risk factor of pancreatic cancer. DOI 10.1038/s41598-025-21200-5 ↗
Björn Andreas Grüning · 1 shared paper, 2022
- Paper Non-coding RNAs underlying the pathophysiological links between type 2 diabetes and pancreatic cancer: A systematic rev… DOI 10.1111/jdi.13727 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.